MTD has a higher market value than 91.76% of US stocks; more precisely, its current market capitalization is $24,684,889,559.
Mettler Toledo International Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.15% of US listed stocks.
MTD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 5,355.4 -- higher than 99.36% of US-listed equities with positive expected earnings growth.
Stocks that are quantitatively similar to MTD, based on their financial statements, market capitalization, and price volatility, are TRU, CSGP, GOOS, MED, and NEOG.
MTD's SEC filings can be seen here. And to visit Mettler Toledo International Inc's official web site, go to www.mt.com.
Mettler-Toledo International, Inc. (MTD) Company Bio
Mettler-Toledo International is a provider of weighing instruments for use in laboratory, industrial and food retailing applications. The Company is also a provider in analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development and process analytics instruments used for in-line measurement in production processes. As well, the company supplies inspection systems used in production and packaging for food, pharmaceutical and other industries. The company was founded in 1991 and is based in Columbus, Ohio.
MTD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Mettler Toledo International Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Mettler Toledo International Inc ranked in the 19th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MTD, they are:
The company's debt burden, as measured by earnings divided by interest payments, is 18.18 -- which is good for besting 82.45% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than only 14.38% of the free cash flow producing stocks we're observing.
MTD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 44.34% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
AZN, CNMD, NRC, MMSI, and ABC can be thought of as valuation peers to MTD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
COLUMBUS, Ohio and BOSTON, Aug. 13, 2020 /PRNewswire/ -- METTLER TOLEDO International Inc. (NYSE: MTD) and TetraScience, Inc. announce a new collaboration to knock down life sciences R&D data silos by providing complete and unified R&D data in the cloud. The integration will join METTLER…
Mettler Toledo (MTD) reports Q2 revenue $690.67M (-5.6% Y/Y), beating consensus.By region, local currency sales decreased 2% in the Americas, 5% in Europe and 3% in Asia/Rest of World.Adjusted operating profit amounted to $317.9M (-2% Y/Y)Q3 outlook: Sales to decline 1%-3%, Adjusted EPS is forecasted to be in the range of $5.80-6.00.2020 full-year outlook: Sales...